Chemotherapy in aggressive T-cell non-Hodgkin lymphoma
10.3760/cma.j.issn.1673-422X.2011.08.022
- VernacularTitle:侵袭性T细胞非霍奇金淋巴瘤的化疗
- Author:
Yu CHEN
;
Kangsheng GU
- Publication Type:Journal Article
- Keywords:
Lymphoma,T-cell;
Drug therapy
- From:
Journal of International Oncology
2011;38(8):629-629
- CountryChina
- Language:Chinese
-
Abstract:
T-cell non-Hodgkin lymphoma is a group disease with unique clinical and pathological features. It is more aggressive and has lower chemotherapy sensitivity than B-cell lymphoma. In recent years, to search for effective treatment, novel agents such as gemcitabine, targeted therapy combined with chemotherapy and high-dose chemotherapy combined with hematopoietic stem cell transplantation are applied in the treatmentof T-cell non-Hodgkin lymphoma. And some progresses are achieved.
